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Table 1  Examples of anti-adhesion studies as inhibitors bacterial pathogens
Material group or anti-adhe-
sion
Anti-adhesive mechanism Year Location Authors Animal References
Multivalent adhesion molecule 
(MAM7) coupled to polysty-
rene microbeads
Blocking pilus assembly or 
function in P. aeruginosa
2017 Birmingham Roberts et al. In vivo rat model [87]
PilQ/PilA antigen of P. aerugi-
nosa (vaccine)
Anti-pili in P. aeruginosa 2017 Iran Gholami et al. In vivo mouse model [88]
Chitosans Inhibition of the growth and 
adhesion of human uropatho-
gens
2017 Italy Campana et al. In vitro [89]
Salvianolic acid B Anti-pili of  N. meningitidis 2016 Finland Huttunen In vitro [90]
Quercetin-mediated nanopar-
ticles
 Anti-adhesive activity against 
B. subtilis biofilm
2016 Egypt Raie et al. In vitro [91]
Phaleria macrocarpa Anti-adhesion and anti-biofilm 
agent against S. mutans
2015 Malaysia Heana et al. In vitro [92]
Essential oils (EOs) Anti-adhesive potential against 
a foodborne pathogen Salmo-
nella strain
2015 Tunisia Miladi et al. In vitro [93]
Monoclonal antibody Against pneumococcal type I 
pilus (RrgA)
2015 Italy Amerighi et al. In vitro [94]
Designed peptides Blocking the binding of AAF-
II EAEC
2015 India Gupta et al. In vitro [95]
Calixarene-based glycoclusters Anti-adhesive of P. aeruginosa 2014 France Boukerb et al. In vivo mouse model [96]
Cranberry bioactives P-fimbrial of E. coli 2013 Not determined Kaspar et al. Ex vivo [97]
Synthetic-mannosides FimH of E.coli 2013 Germany Fessele et al. In vitro [98]
Flavonoid rich extract of Gly-
cyrrhiza glabra (GutGard)
H. pylori (inhibit DNA gyrase, 
dihydrofolate reductase, 
protein synthesis)
2012 India Asha et al. In vitro [99]
S-carboxymethylcysteine (S-
CMC)
Reducing the expression of 
host receptors for S. pneu-
moniae
2011 Japan Sumitomo et al. In vitro [100]
High molecular weight coffee 
components
Inhibiting the ability of S. 
mutans
2010 Italy Stauder et al. In vitro [101]
Cranberry P-fimbriae of E. coli 2010 France Howell et al. ex-vivo/in vivo [102]
Lactobacillus rhamnosus GG Reduction of adhesion and 
cytotoxicity of S. Typhimu-
rium
2009 USA Burkholder et al. In vitro [103]
Wine components Anti-adhesion and anti-biofilm 
activity against S. mutans
2009 Italy Daglia et al. In vitro/ex vivo [104]
Sialyloligosaccharides (SOS) Inhibition of V. cholerae toxin 
(Ctx) binding to GM1-OS
2009 United Kingdom Sinclair et al. In vitro [105]
Monosaccharide Inhibition of adherence by 
P. aeruginosa to canine 
corneocytes
2008  England McEwan et al. In vivo [106]
Ceramic-composite S. mutans 2007 Germany Rosentritt et al. In vitro [107]
